(Q43540159)

English

Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy

scientific article published in January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy (English)

1 reference

Europe PubMed Central

24 November 2017

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Talvensaari-Mattila A

1

1 reference

Europe PubMed Central

24 November 2017

Pääkko P

2

1 reference

Europe PubMed Central

24 November 2017

Blanco-Sequeiros G

3

1 reference

Europe PubMed Central

24 November 2017

Turpeenniemi-Hujanen T

4

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

24 November 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

24 November 2017

65

1 reference

Europe PubMed Central

24 November 2017

1

1 reference

Europe PubMed Central

24 November 2017

55-61

1 reference

Europe PubMed Central

24 November 2017

https://scigraph.springernature.com/pub.10.1023/a:1006458601568

0 references

Tumor size and axillary metastasis, a correlative occurrence in 1244 cases of breast cancer between 1980 and 1995.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Activity of type IV collagenases in benign and malignant breast disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Type IV collagenases in invasive tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

21 January 2018

Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

7 January 2021

based on heuristic

inferred from DOI database lookup

Laminin receptors, collagenase IV and prognosis in node-negative breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

7 January 2021

based on heuristic

inferred from DOI database lookup

72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006458601568

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1006458601568

1 reference

Europe PubMed Central

24 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43540159&oldid=2098191527"